Bacitracin EP Impurity E
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

22601-63-4Bacitracin EP Impurity E

● In Stock

Catalogue No.:VE0022984
CAS No.:22601-63-4
Mol. Formula:C66H98N16O17S
Mol. Weight:1419.67 g/mol

Additional information on CAS 22601-63-4

Parent drug

Bacitracin

IUPAC Name

(R)-5-(((2S,3S)-1-(((3S,6R,9S,12R,15S,18R,21S)-9-((1H-imidazol-4-yl)methyl)-3-(2-amino-2-oxoethyl)-18-(3-aminopropyl)-12-benzyl-15-((S)-sec-butyl)-6-(carboxymethyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10, 13,16,19-heptaazacyclopentacosan-21-yl)amino)-3-methyl-1-oxopentan-2-yl)amino)-4-((S)-4-methyl-2-(2-((S)-2-methylbutanoyl)thiazole-4-carboxamido)pentanamido)-5-oxopentanoic acid

Pharmacopoeial Synonyms

Bacitracin F

Other Synonyms

N/A

Description

Bacitracin EP Impurity E (CAS 22601-63-4) is a defined bacitracin-associated peptide impurity with molecular formula C66H98N16O17S and molecular weight 1419.67 g/mol. It represents a structurally close higher-mass analog of the bacitracin cyclic peptide complex, consistent with product-related heterogeneity arising during fermentation, processing, or limited proteolytic transformation. Because of its polar, multifunctional peptide architecture, characterization typically relies on reversed-phase LC coupled to high-resolution MS or LC-MS/MS, often with orthogonal UV and, when needed, ion-exchange profiling. Its monograph significance lies in monitoring process-derived impurities and compositional drift within bacitracin materials.

Request a Quote

« * » indique les champs nécessaires

Ce champ n’est utilisé qu’à des fins de validation et devrait rester inchangé.
Products quotation
Name
Url